BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 21940646)

  • 1. Effects of ranolazine on cloned cardiac kv4.3 potassium channels.
    Kim HJ; Ahn HS; Choi JS; Choi BH; Hahn SJ
    J Pharmacol Exp Ther; 2011 Dec; 339(3):952-8. PubMed ID: 21940646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of riluzole with the closed inactivated state of Kv4.3 channels.
    Ahn HS; Kim SE; Jang HJ; Kim MJ; Rhie DJ; Yoon SH; Jo YH; Kim MS; Sung KW; Hahn SJ
    J Pharmacol Exp Ther; 2006 Oct; 319(1):323-31. PubMed ID: 16815868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Block of cloned Kv4.3 potassium channels by dapoxetine.
    Jeong I; Kim SW; Yoon SH; Hahn SJ
    Neuropharmacology; 2012 Jun; 62(7):2261-6. PubMed ID: 22192593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duloxetine blocks cloned Kv4.3 potassium channels.
    Choi JS; Hahn SJ
    Brain Res; 2012 Jul; 1466():15-23. PubMed ID: 22618310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Open channel block of A-type, kv4.3, and delayed rectifier K+ channels, Kv1.3 and Kv3.1, by sibutramine.
    Kim SE; Ahn HS; Choi BH; Jang HJ; Kim MJ; Rhie DJ; Yoon SH; Jo YH; Kim MS; Sung KW; Hahn SJ
    J Pharmacol Exp Ther; 2007 May; 321(2):753-62. PubMed ID: 17312186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diltiazem inhibits hKv1.5 and Kv4.3 currents at therapeutic concentrations.
    Caballero R; Gómez R; Núñez L; Moreno I; Tamargo J; Delpón E
    Cardiovasc Res; 2004 Dec; 64(3):457-66. PubMed ID: 15537499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of haloperidol on Kv4.3 potassium channels.
    Lee HJ; Sung KW; Hahn SJ
    Eur J Pharmacol; 2014 Oct; 740():1-8. PubMed ID: 24998874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Kv4.3 by genistein via a tyrosine phosphorylation-independent mechanism.
    Kim HJ; Ahn HS; Choi BH; Hahn SJ
    Am J Physiol Cell Physiol; 2011 Mar; 300(3):C567-75. PubMed ID: 21148405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raloxifene inhibits cloned Kv4.3 channels in an estrogen receptor-independent manner.
    Chae YJ; Kim DH; Lee HJ; Sung KW; Kwon OJ; Hahn SJ
    Pflugers Arch; 2015 Aug; 467(8):1663-76. PubMed ID: 25231973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Block of Kv4.3 potassium channel by trifluoperazine independent of CaMKII.
    Chae YJ; Choi BH; Choi JS; Hahn SJ
    Neurosci Lett; 2014 Aug; 578():159-64. PubMed ID: 24993295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carvedilol blocks the cloned cardiac Kv1.5 channels in a β-adrenergic receptor-independent manner.
    Jeong I; Choi BH; Yoon SH; Hahn SJ
    Biochem Pharmacol; 2012 Feb; 83(4):497-505. PubMed ID: 22146582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ranolazine reduces neuronal excitability by interacting with inactivated states of brain sodium channels.
    Kahlig KM; Hirakawa R; Liu L; George AL; Belardinelli L; Rajamani S
    Mol Pharmacol; 2014 Jan; 85(1):162-74. PubMed ID: 24202911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Kv4.3 potassium channels by trazodone.
    Chae YJ; Choi JS; Hahn SJ
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Aug; 386(8):711-9. PubMed ID: 23615873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of mosapride on Kv4.3 potassium channels expressed in CHO cells.
    Sung KW; Hahn SJ
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Oct; 386(10):905-16. PubMed ID: 23793103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arachidonic acid potently inhibits both postsynaptic-type Kv4.2 and presynaptic-type Kv1.4 IA potassium channels.
    Angelova PR; Müller WS
    Eur J Neurosci; 2009 May; 29(10):1943-50. PubMed ID: 19453640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosiglitazone inhibits Kv4.3 potassium channels by open-channel block and acceleration of closed-state inactivation.
    Jeong I; Choi BH; Hahn SJ
    Br J Pharmacol; 2011 Jun; 163(3):510-20. PubMed ID: 21232039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reverse use dependence of Kv4.2 blockade by 4-aminopyridine.
    Tseng GN; Jiang M; Yao JA
    J Pharmacol Exp Ther; 1996 Nov; 279(2):865-76. PubMed ID: 8930194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of lobeline, a nicotinic receptor ligand, on the cloned Kv1.5.
    Jeong I; Choi BH; Hahn SJ
    Pflugers Arch; 2010 Oct; 460(5):851-62. PubMed ID: 20734202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the cloned delayed rectifier K+ channels, Kv1.5 and Kv3.1, by riluzole.
    Ahn HS; Choi JS; Choi BH; Kim MJ; Rhie DJ; Yoon SH; Jo YH; Kim MS; Sung KW; Hahn SJ
    Neuroscience; 2005; 133(4):1007-19. PubMed ID: 15964489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of MiRP1 and DPP6 beta-subunits on the blockade induced by flecainide of Kv4.3/KChIP2 channels.
    Radicke S; Vaquero M; Caballero R; Gómez R; Núñez L; Tamargo J; Ravens U; Wettwer E; Delpón E
    Br J Pharmacol; 2008 Jun; 154(4):774-86. PubMed ID: 18536731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.